beyondthedish.wordpress.com
Mesoblast Phase Degenerative Disc Disease Treatment Receives Positive Feedback from European Regulatory Agencies
Mesoblast Limited announced that European Medicines Agency has approved expansion of their Phase 3 clinical program of its product candidate MPC-06-1D for degenerative disc disease. Mesoblast&#8217…